# Targeted visual and terminology refinements — October 20, 2026

## Scope and files

Updated the existing page in its project folder. No file was moved, renamed, staged, committed or pushed. The pre-existing parent `research.html` modification and other untracked projects were left untouched.

Production source changes:

- `2026-10-19-budget-impact-analysis-medication.html`: eight coloured inline vector illustrations; removal of only the requested animation sentence; compact severity-copy grouping; first-use acronym expansions and a closed terminology reference; contextualized historical comparison; introductory Special Authority paragraph; PLIS distinctions; requested metadata values.
- `css/revision.css`: compact context, severity, Venn, terminology and metadata styles with mobile treatment.
- `js/education.js`: redesigned conceptual overlap with external labels and three numbered regions; compact, accessible organizational labels in the approval pathway.
- `js/app.js`: expanded data-source terminology and PLIS roles; full-name tooltips for compact secukinumab table headers. No calculations or CSV handler changed.
- `js/storyboard.js`: terminology and PLIS explanations in captions and relevant labels. No scene durations, motion logic or numerical values changed. The linked-record scene explicitly labels PLIS as supplementary HS context with conditional access.
- `js/illustrations.js` and new `js/terminology.js`: accessible SVG descriptions expand compact abbreviations without widening diagrams.
- `js/assumptions.js`: reference titles expanded and a primary clinical-diagnosis reference added; all controls, defaults and assumption definitions are unchanged.
- `README.md`: links to this report and the focused patch.

QA additions and refreshed results: `scripts/review-targeted-refinements.mjs`, measurement/validation JSON files under `data/`, and before/after captures under `figures/qa/targeted-refinements/`. Existing numerical, presentation, revision and browser reports were refreshed. `targeted-refinements.patch` contains the focused text diff for the ten source/documentation files above, including the new review script.

## Measured layout changes

Dimensions are CSS pixels at a 1440×1000 desktop viewport; the same content was reviewed at 390×844 mobile and tested at 820×1180 tablet.

| Element | Before | After | Result |
|---|---:|---:|---|
| Broad-context section | 1164×712 | 1164×604 | About 15% shorter; all eight labels/keywords and related-questions explanation preserved |
| Each Hurley card | 355×370 | 355×205 | About 55% of former height; all text retained |
| Each severity illustration | 240×185 | 144×111 | Consistent 60% linear scale; silhouette, involvement and checklist retained |
| Prevalence overlap figure | 1102×406 | 780×254 | About 71% width and 63% height |
| Metadata | 252×141 | 238×116 | Four compact, nonwrapping desktop rows |

On mobile the severity cards stack at approximately 332×185 each, compared with 332×369 before. The Venn figure fits the available 332px width with normally sized HTML definitions and region explanations instead of requiring a horizontally clipped 620px SVG. Numbers identify the three regions; the set areas remain schematic and have no numerical prevalence encoding.

## Interpretation and terminology

- The Venn diagram distinguishes true cases missed by records, true cases captured in records, and possible false positives/misclassified administrative records. Set labels are outside the overlap.
- Expanded or explained BIA/BI, CDA-AMC/CADTH, pCPA, DAD, MSP, NACRS, PLIS, HS, BC, CAD, ICD and its relevant variants, DIN, SQL, CIHI, CMDB, PPV, QALYs, CV, CRP, ALT, dosing shorthand and file-format terms. Compact diagrams retain short labels with full accessible SVG descriptions; the terminology reference opens on demand.
- The original review’s Appendix 5, especially pp. 173–179 and Table 19, was inspected locally. The historical sponsor total is CAD 76,542,993 and the combined reanalysis total is CAD 9,547,349; the national graphic and table now consistently show **CAD millions**, rounded to 76.54 and 9.55. These remain alternative historical model estimates for participating Canadian public drug plans, including BC. They are not observed BC expenditure, a national-versus-BC comparison, or a direct price-negotiation effect. The existing BC calculator and its separate illustrative view are unchanged.
- Added BC-specific population, use, eligibility, market-share, pricing, reimbursement and cost-sharing context, and the conditions for a meaningful per-treated-patient comparison. No arbitrary denominator or new per-patient number was introduced.
- Special Authority is introduced as a criteria-based PharmaCare process with prescriber documentation and plan-dependent reimbursement; approval is not presented as necessarily eliminating patient payment. Detailed form criteria remain intact.
- Laboratory records may help identify cohorts where validated laboratory-based criteria exist. For this HS example, PLIS is supplementary context rather than an independent diagnostic source. Conditional or unavailable research access and the synthetic nature of all patient examples remain explicit in source panels, captions, methods and limitations. No PLIS-positive patient set was added.
- Metadata now reads Created: October 19, 2026; Harness: Codex on Windows; Model: GPT-6.1 Codex; Reasoning: High, as requested. Title and subtitle were preserved.

Sources checked for the wording: [BC Special Authority](https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/pharmacare/programs/special-authority), [BC research-data management](https://www2.gov.bc.ca/gov/content/health/conducting-health-research-evaluation/data-access-health-data-central/data-management-oversight), [North American HS clinical guidelines, diagnosis and diagnostic testing](https://pmc.ncbi.nlm.nih.gov/articles/PMC9131894/), [NIAMS clinical diagnosis information](https://www.niams.nih.gov/health-topics/hidradenitis-suppurativa-hs/diagnosis-treatment-and-steps-to-take), [CIHI CMDB terminology](https://www.cihi.ca/en/canadian-management-information-system-database-cmdb-metadata), and [ISPOR’s official society name](https://www.ispor.org/about/our-society). The BC policy/data endpoints intermittently returned gateway errors to direct fetch; official indexed descriptions and the existing linked documents were also checked. No new clinical eligibility rule was inferred from those access failures.

## Verification

- Numerical suite: **2,769 checks PASS**, including original cohorts, dosing, transitions, payer reconciliation, sensitivity and seeded simulation invariants.
- Revision suite: **114 checks PASS**; presentation suite: **46 checks PASS**.
- Actual Chrome browser regression: **desktop, tablet and mobile PASS**, with working charts, model edits/reset, Special Authority inputs, timeline/speed/play/pause/replay, real CSV download, keyboard focus, repeatable Monte Carlo, no external runtime requests and zero console errors.
- Static local paths, DOM IDs and module dependencies pass.
- Focused preservation/geometry audit: **10 checks PASS**. Verified unchanged title/subtitle, related-questions explanation, all eight domain labels/keywords, every severity sentence, individual chapter durations, all controls/defaults/assumptions and CSV handler. Desktop compactness ratios fall within the requested ranges; no document overflow or console errors in either measured viewport.
- `js/model.js`, `js/video.js`, `js/budget-view.js` and the original PDF retain their pre-revision SHA-256 hashes; see `targeted-protected-hashes.json`.
- Inspected desktop/mobile captures of context, severity, Venn, metadata, national comparison, Special Authority, glossary, and relevant clinical-data scenes. Sticky research navigation is temporarily made static only while capturing individual subsection images; published behavior is unchanged.

No remaining issue was identified in the tested layouts. Touch hardware and a screen-reader session were not tested.

## Reviewing changes

From this project folder:

```powershell
git status --short -- .
git diff -- .
git apply --stat data/targeted-refinements.patch
Get-Content data/targeted-refinements.patch
```

The project folder was already untracked at the start of this revision, so ordinary `git diff` does not enumerate these files. The focused patch records this turn’s source changes without staging anything. `git apply --stat` displays statistics only; it does not apply the patch.
